Celgene (CELG) Stock Rising Ahead of Earnings Results

NEW YORK (TheStreet) -- Celgene (CELG - Get Report) will report its 2015 third quarter earnings results before the market open on Thursday morning.

Analysts surveyed by Thomson Reuters estimate that the Summit, NJ-based biopharmaceutical company will report earnings of $1.22 per share on revenue of $2.4 billion.

Celgene reported earnings of 97 cents per share on revenue of $1.98 billion for the third quarter of 2014.

STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks with serious upside potential. See them FREE for 14-days.

Last week, the company announced that its acute myeloid leukaemia treatment for older patients was approved by the European Commission.

Shares of Celgene were up by 1.05% to $127.85 in mid-afternoon trading on Wednesday.

Separately, TheStreet Ratings team rates CELGENE CORP as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation:

We rate CELGENE CORP (CELG) a...